Cargando…

Diastolic Cardiac Function Improvement by Liraglutide Is Mainly Body Weight Reduction Dependent but Independently Contributes to B-Type Natriuretic Peptide Reduction in Patients with Type 2 Diabetes with Preserved Ejection Fraction

OBJECTIVES: A single-arm prospective study was conducted among Japanese patients with type 2 diabetes having preserved ejection fraction. The aim was to investigate (1) whether liraglutide therapy could improve B-type natriuretic peptide (BNP) levels and diastolic cardiac function assessed by the E-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yagi, Kunimasa, Imamura, Teruhiko, Tada, Hayato, Chujo, Daisuke, Liu, Jianhui, Shima, Yuuki, Ohbatake, Azusa, Miyamoto, Yukiko, Okazaki, Satoko, Ito, Naoko, Nakano, Kaoru, Shikata, Masataka, Enkaku, Asako, Takikawa, Akiko, Honoki, Hisae, Fujisaka, Shiho, Origasa, Hideki, Tobe, Kazuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019623/ https://www.ncbi.nlm.nih.gov/pubmed/33855087 http://dx.doi.org/10.1155/2021/8838026

Ejemplares similares

Fragmented QRS on electrocardiography as a predictor for diastolic cardiac dysfunction in type 2 diabetes
por: Yagi, Kunimasa, et al.
Publicado: (2022)

Anti‐programmed death ligand 1 therapy‐induced type 1 diabetes presenting with multiple islet‐related autoantibodies
por: Honoki, Hisae, et al.
Publicado: (2019)

High prevalence of fragmented QRS on electrocardiography in Japanese patients with diabetes irrespective of metabolic syndrome
por: Yagi, Kunimasa, et al.
Publicado: (2021)

Perioperative C‐peptide index is associated with the status of diabetes management after pancreatectomy
por: Shikata, Masataka, et al.
Publicado: (2022)

Ratio of low molecular weight serum adiponectin to the total adiponectin value is associated with type 2 diabetes through its relation to increasing insulin resistance
por: Iwata, Minoru, et al.
Publicado: (2018)

A New Method for Albuminuria Measurement Using a Specific Reaction between Albumin and the Luciferin of the Firefly Squid Watasenia scintillans
por: Ishimoto, Tetsuya, et al.
Publicado: (2022)

Sirt1 activator induces proangiogenic genes in preadipocytes to rescue insulin resistance in diet-induced obese mice
por: Nawaz, Allah, et al.
Publicado: (2018)

Publisher Correction: Sirt1 activator induces proangiogenic genes in preadipocytes to rescue insulin resistance in diet-induced obese mice
por: Nawaz, Allah, et al.
Publicado: (2018)

Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to date
por: Howell, Rebecca, et al.
Publicado: (2019)

Family history of diabetes in both parents is strongly associated with impaired residual β‐cell function in Japanese type 2 diabetes patients
por: Iwata, Minoru, et al.
Publicado: (2019)

The gut microbiome: a core regulator of metabolism
por: Fujisaka, Shiho, et al.
Publicado: (2022)

An association between liraglutide treatment and reduction in excessive daytime sleepiness in obese subjects with type 2 diabetes
por: Gomez-Peralta, Fernando, et al.
Publicado: (2015)

Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus
por: Okada, Kenta, et al.
Publicado: (2014)

Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
por: Frøssing, Signe, et al.
Publicado: (2017)

Efficacy and safety of liraglutide added to insulin therapy in elderly patients with type 2 diabetes
por: Tonoike, Mie, et al.
Publicado: (2018)

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
por: Buse, John B., et al.
Publicado: (2020)

C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study
por: Ohbatake, Azusa, et al.
Publicado: (2019)

Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)
por: Dahlqvist, Sofia, et al.
Publicado: (2018)

Astaxanthin stimulates mitochondrial biogenesis in insulin resistant muscle via activation of AMPK pathway
por: Nishida, Yasuhiro, et al.
Publicado: (2020)

Does Combining Liraglutide with Intragastric Balloon Insertion Improve Sustained Weight Reduction?
por: Mosli, Mahmoud M., et al.
Publicado: (2017)

Impact of Serum Retinol-Binding Protein 4 Levels on Regulation of Remnant-Like Particles Triglyceride in Type 2 Diabetes Mellitus
por: Yamaaki, Naoto, et al.
Publicado: (2013)

Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients
por: Li, Chun-Jun, et al.
Publicado: (2014)

Liraglutide in the management of type 2 diabetes
por: Wajcberg, Estela, et al.
Publicado: (2010)

Secretory units of islets in transplantation index is a useful predictor of insulin requirement in Japanese type 2 diabetic patients
por: Iwata, Minoru, et al.
Publicado: (2013)

Serum Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated with Low Left Ventricular Ejection Fraction and Elevated Plasma Brain-Type Natriuretic Peptide Level
por: Fujita, Shu-ichi, et al.
Publicado: (2017)

Sodium‐glucose cotransporter‐2 inhibitor luseogliflozin added to glucagon‐like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52‐week, open‐label, single‐arm study
por: Seino, Yutaka, et al.
Publicado: (2017)

Erratum: Does combining liraglutide with intragastric balloon insertion improve sustained weight reduction?
Publicado: (2017)

Isoxanthohumol, a hop-derived flavonoid, alters the metabolomics profile of mouse feces
por: FUKIZAWA, Shinya, et al.
Publicado: (2020)

Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome
por: Kim, Yoo-Mi, et al.
Publicado: (2020)

Astaxanthin, a Marine Carotenoid, Maintains the Tolerance and Integrity of Adipose Tissue and Contributes to Its Healthy Functions
por: Nawaz, Allah, et al.
Publicado: (2021)

Macrophage‐specific hypoxia‐inducible factor‐1α deletion suppresses the development of liver tumors in high‐fat diet‐fed obese and diabetic mice
por: Takikawa, Akiko, et al.
Publicado: (2019)

Bofutsushosan improves gut barrier function with a bloom of Akkermansia muciniphila and improves glucose metabolism in mice with diet-induced obesity
por: Fujisaka, Shiho, et al.
Publicado: (2020)

Gut microbiota, determined by dietary nutrients, drive modification of the plasma lipid profile and insulin resistance
por: Watanabe, Yoshiyuki, et al.
Publicado: (2021)

Potential of liraglutide in the treatment of patients with type 2 diabetes
por: Deacon, Carolyn F
Publicado: (2009)

Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
por: Rigato, Mauro, et al.
Publicado: (2014)

GLP-1 Analog Liraglutide Improves Vascular Function in Polymicrobial Sepsis by Reduction of Oxidative Stress and Inflammation
por: Helmstädter, Johanna, et al.
Publicado: (2021)

FTO Gene Polymorphism Is Associated with Type 2 Diabetes through Its Effect on Increasing the Maximum BMI in Japanese Men
por: Kamura, Yutaka, et al.
Publicado: (2016)

Dimensional reduction of type-II superstrings
por: Ferrara, Sergio, et al.
Publicado: (1989)

Anti-obesity effect of a hop-derived prenylflavonoid isoxanthohumol in a high-fat diet-induced obese mouse model
por: FUKIZAWA, Shinya, et al.
Publicado: (2020)

Determining whether the effect of liraglutide on non‐alcoholic fatty liver disease depends on reductions in the body mass index
por: Shiomi, Megumi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6gup77l24qj4fbubjmp290knrl